These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 727767)

  • 1. Activity of derivatives and analogs of dapsone against Mycobacterium leprae.
    Levy L
    Antimicrob Agents Chemother; 1978 Nov; 14(5):791-3. PubMed ID: 727767
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Bactericidal action of dapsone against Mycobacterium leprae in mice.
    Levy L
    Antimicrob Agents Chemother; 1976 Apr; 9(4):614-7. PubMed ID: 773300
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Activity of the combination of isoniazid, protionamide and dapsone against Mycobacterium leprae and some other mycobacteria.
    Pattyn SR; Portaels F; Van Loo G; Van den Breen L
    Arzneimittelforschung; 1981; 31(12):2155-7. PubMed ID: 7037011
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Dapsone chemotherapy of Mycobacterium leprae infection of the neonatally thymectomized Lewis rat.
    Fieldsteel AH; Levy L
    Am J Trop Med Hyg; 1976 Nov; 25(6):854-9. PubMed ID: 795312
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Susceptibility of thymectomized and irradiated mice to challenge with several organisms and the effect of dapsone on infection with Mycobacterium leprae.
    Levy L; Ng H; Evans MJ; Krahenbuhl JL
    Infect Immun; 1975 May; 11(5):1122-32. PubMed ID: 804443
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Rifampin therapy of lepromatous leprosy.
    Am J Trop Med Hyg; 1975 May; 24(3):475-84. PubMed ID: 1098495
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Combined rifampin and dapsone chemotherapy of Mycobacterium leprae infection of the neonatally thymectomized Lewis rat.
    Fieldsteel AH; Levy L
    Int J Lepr Other Mycobact Dis; 1980 Sep; 48(3):267-76. PubMed ID: 7002811
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Superiority of the neonatally thymectomized Lewis rat (NTLR) to monitor a clinical trial in lepromatous leprosy of the two regimens of rifampin and dapsone.
    Gelber RH; Humphres RC; Fieldsteel AH
    Int J Lepr Other Mycobact Dis; 1986 Jun; 54(2):273-83. PubMed ID: 3522770
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Some characteristics of the action of dapsone on multiplication of Mycobacterium leprae in the mouse.
    Levy L; Peters JH
    Lepr Rev; 1977 Dec; 48(4):237-45. PubMed ID: 400808
    [No Abstract]   [Full Text] [Related]  

  • 10. Primary dapsone-resistant leprosy in Cebu, Philippines.
    Guinto RS; Cellona RV; Fajardo TT; de la Cruz EC
    Int J Lepr Other Mycobact Dis; 1981 Dec; 49(4):427-30. PubMed ID: 7042607
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Experimental and clinical studies on rifampicin in treatment of leprosy.
    Rees RJ; Pearson JM; Waters MF
    Br Med J; 1970 Jan; 1(5688):89-92. PubMed ID: 4903972
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Studies on dapsone-resistant Mycobacterium leprae in leprosy patients of Gudiyatham Taluk, the leprosy control area of the Schieffelin Leprosy Research and Training Centre, Karigiri. 2. A progress report.
    Almeida JG; Christian M; Chacko CJ; Taylor PM; Fritschi EP
    Lepr Rev; 1983 Sep; 54(3):185-91. PubMed ID: 6355722
    [No Abstract]   [Full Text] [Related]  

  • 13. Dihydropteroate synthase mutations in the folP1 gene predict dapsone resistance in relapsed cases of leprosy.
    Cambau E; Carthagena L; Chauffour A; Ji B; Jarlier V
    Clin Infect Dis; 2006 Jan; 42(2):238-41. PubMed ID: 16355335
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Primary dapsone-resistant Hansen's disease in California. Experience with over 100 Mycobacterium leprae isolates.
    Gelber RH; Rea TH; Murray LP; Siu P; Tsang M; Byrd SR
    Arch Dermatol; 1990 Dec; 126(12):1584-6. PubMed ID: 2256685
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Susceptibility of Mycobacterium leprae to dapsone as a determinant of patient response to acedapsone.
    Levy L; Peters JH
    Antimicrob Agents Chemother; 1976 Jan; 9(1):102-12. PubMed ID: 769667
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Primary dapsone-resistant leprosy in San Francisco.
    Gelber RH
    Int J Lepr Other Mycobact Dis; 1984 Dec; 52(4):471-4. PubMed ID: 6399067
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Chemotherapy of leprosy in multibacillary nude mice.
    Hastings RC; Chehl SK
    Indian J Lepr; 1991; 63(3-4):350-5. PubMed ID: 1804889
    [No Abstract]   [Full Text] [Related]  

  • 18. A Mycobacterium leprae isolate resistant to dapsone, rifampin, ofloxacin and sparfloxacin.
    Matsuoka M; Kashiwabara Y; Namisato M
    Int J Lepr Other Mycobact Dis; 2000 Dec; 68(4):452-5. PubMed ID: 11332288
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Synthesis and antileprosy activity of some dialkyldithiocarbamates.
    Makarov V; Riabova OB; Yuschenko A; Urlyapova N; Daudova A; Zipfel PF; Möllmann U
    J Antimicrob Chemother; 2006 Jun; 57(6):1134-8. PubMed ID: 16595643
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prevalence survey of secondary dapsone resistance in leprosy in Kancheepuram and Tiruvannamalai control units of Tamil Nadu.
    Neelan PN; Noordeen SK; Balakrishnan S; Pandian PR
    Lepr India; 1983 Apr; 55(2):222-30. PubMed ID: 6355650
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.